Effective: 04/01/2020 C4418-A, C4588-A, C7007-A, C7010-A, C7834-A, C8044-A, C11883-A 12-2019 & 01-2020 2 of 3
Proprietary
anemia and/or reduce uterine size prior to planned
surgical intervention?
Endometrial Thinning for Dysfunctional Uterine Bleeding
Is requested medication prescribed to thin endometrium prior to planned endometrial ablation OR hysterectomy
within next 4-8 weeks?
Central Precocious Puberty
Was an MRI OR CT Scan performed to rule out
brain lesions OR tumors?
Does member have onset of secondary
sexual characteristics earlier than 8
years in females AND 9 years in males?
Was there response to GnRH stimulation test (or
other labs to support CPP, such as LH level,
estradiol AND testosterone level)?
Was bone age advanced 1 year beyond
chronological age?
Was there clinical response to treatment (for example, pubertal slowing or decline, height velocity, bone age,
estradiol AND testosterone level)?
Is member at least 18 years of age AND premenopausal at time of diagnosis?
Advanced Ovarian Cancer
Member cannot tolerate OR does not respond
to cytotoxic regimens?
Is drug requested being used for post-
operative management?
Does member have androgen receptor
positive recurrent disease with distant
Is there a performance status score of 0 – 3
by ECOG standards?
Gender Dysphoria/Gender Incongruence in adolescents
Was medication prescribed by Pediatric
Endocrinologist that collaborated care with a
Mental Health Provider?
Does member show persistent, well-
documented diagnosis of gender non-
conformity OR dysphoria that worsened with
Does member exhibit signs of puberty with
minimum Tanner stage 2?
Has member made a fully informed decision
AND given consent, AND parent/guardian
consents to treatment OR member has been
Are member’s comorbid conditions reasonably
controlled?
Was member educated on any
contraindications AND side effects to
Was member informed of fertility preservation options prior to treatment?
Are there lab results to support response to treatment (for example, FSH, LH, weight, height, tanner stage, bone
age)?
Gender Dysphoria/Gender Incongruence in Adults
Was requested medication prescribed by
Endocrinologist that collaborated care with a
Does member show persistent, well-
documented diagnosis of gender dysphoria /
Does member have capacity to make a fully
informed decision and consents to treatment?
Are mental health concerns, if present,
reasonably well controlled?
Was member informed of fertility preservation options prior to treatment?
Are there lab results to support response to treatment (for example, FSH, LH, weight, height, tanner stage, bone
age)?
Additional information the prescribing provider feels is important to this review. Please specify below or submit medical records